about
Determinants of aortic stiffness: 16-year follow-up of the Whitehall II studyMoving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groupsEffect of secular trends on age-related trajectories of cardiovascular risk factors: the Whitehall II longitudinal study 1985-2009.Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study.Association between protein signals and type 2 diabetes incidenceReduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetesHbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis.Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort studyAssociations between ultrasound measures of abdominal fat distribution and indices of glucose metabolism in a population at high risk of type 2 diabetes: the ADDITION-PRO studyEffect of intensive multifactorial treatment compared with routine care on aortic stiffness and central blood pressure among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark studyBimodal distribution of glucose is not universally useful for diagnosing diabetesTrajectories of body mass index before the diagnosis of cardiovascular disease: a latent class trajectory analysis.Progression to impaired glucose regulation and diabetes in the population-based Inter99 study.Impact of glucose tolerance status, sex, and body size on glucose absorption patterns during OGTTs.Cardiovascular risk stratification and management in pre-diabetes.Associations between glycaemic deterioration and aortic stiffness and central blood pressure: the ADDITION-PRO Study.Physical Activity Dimensions Associated with Impaired Glucose Metabolism.High and low vitamin D level is associated with cardiovascular autonomic neuropathy in people with Type 1 and Type 2 diabetes.Glycaemic threshold for diabetes-specific retinopathy among individuals from Saudi Arabia, Algeria and Portugal.Risk scores for diabetes and impaired glycaemia in the Middle East and North Africa.Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk.The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes.Global healthcare expenditure on diabetes for 2010 and 2030.Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus: The Steno Type 1 Risk Engine.Metabolically Healthy Obesity and Ischemic Heart Disease: A 10-Year Follow-Up of the Inter99 Study.Vitamin B12 deficiency is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes.Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study.Cardiovascular risk factors in rural Kenyans are associated with differential age gradients, but not modified by sex or ethnicity.Intensive multifactorial treatment modifies the effect of family history of diabetes on glycaemic control in people with Type 2 diabetes: a post hoc analysis of the ADDITION-Denmark randomized controlled trial.Glucose-Dependent Insulinotropic Polypeptide Is Associated With Lower Low-Density Lipoprotein But Unhealthy Fat Distribution, Independent of Insulin: The ADDITION-PRO Study.Geographic differences in the associations between impaired glucose regulation and cardiovascular risk factors among young adults.Comment on: Tam et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 2012;35:1605-1610.Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study.A globally applicable screening model for detecting individuals with undiagnosed diabetes.Risk scores for type 2 diabetes can be applied in some populations but not all.HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R.Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study.A cross-sectional study of glycaemic control, complications and psychosocial functioning among 18- to 35-year-old adults with type 1 diabetes.Effect of time of day and fasting duration on measures of glycaemia: analysis from the Whitehall II Study.The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region.
P50
Q28729748-4AB59BBE-7A7F-4056-B85B-0A579E89D410Q33683712-3AC5BDF1-4251-461E-A3F2-4678C38AE6FAQ33736080-A33503D0-4BBC-48D9-9563-58AEC893D892Q33843643-1A275412-6294-4867-892A-EB9CD523E5B0Q34152210-DDA987CE-6363-4224-9E02-C7723924C0D7Q34257123-765928D9-B30B-461B-B2AF-00A3AB988A0AQ34559044-CB59A121-5408-43D8-B1BC-728400FAE78BQ35093473-5C4E736C-FE45-4B77-B56E-CFA62C1BF3D4Q35306604-A89F0C3D-9095-46BE-8801-54F4DE336822Q36334505-00F941EA-9D0B-4596-8238-4129C9D13D12Q37105153-FD14C49F-948A-40EC-9395-D134760F4644Q37116482-5C9929DD-C198-4AD7-BE01-E56BB02DDE36Q37139545-35A52BB3-8446-4AEE-99F0-7CE34B4F360EQ37278088-B9FB1DC7-C74A-46A6-B47E-B37BBE11FB02Q38205374-8D3D9555-037B-4E5E-A69F-8DFB3A544B90Q38683242-948B7220-AA04-499D-AF6E-49F1E7408315Q38686327-E6D4103A-8E4F-4073-B1C4-96D09FB0A0D4Q38815364-B489A629-DD18-4C3E-8D02-38901B2167CFQ38870195-9144BB2D-C802-4FD5-B53E-40FD22F75669Q39044396-49A19F22-F78B-4335-B3C6-43EF8E6BC502Q39325486-70B7AE51-6D82-476D-83BB-5E207730F255Q39806254-AD027619-2089-4B37-8E4D-94452763266EQ39899138-996F7349-14E0-40BD-897E-C80559419A4BQ39988897-B0D69DEA-A86E-4DBC-B669-C50EA02458AAQ40282619-F6E9AC92-6F7C-49F9-B034-A063283CEA76Q40577755-B0FC3FCD-B3A4-4760-B6A3-51593B9BB2EFQ40636102-398F76B9-939A-45B9-8C64-D5713B8A8E93Q40836540-BE4D8E33-23D3-42A8-9BC1-9C2B01FFE3EDQ41145702-DC3E7BA7-123C-432A-AF07-A978B1904F14Q41181012-40899FAB-85E6-46D1-88EE-BAB1C2596487Q41670291-8D00774C-9C7A-4275-AE6C-682915FB3620Q42419413-54197959-6F02-45FD-8605-1BE9A89C33C3Q42960858-73634420-5B46-4EAF-AE1C-E1D39A564B5DQ43649225-D46E2770-7E29-49CF-A686-1FF00BFF8862Q43817158-824D9610-E0F9-48F5-A512-B3E130CA1FF1Q44606522-549A80CD-AC80-4743-A585-A2C85FD2D09DQ45497146-B4E0FF6F-62D3-433C-9377-387F76B3BB37Q46174155-984DD916-9FBD-484F-A45F-AC63D305E242Q46325495-B2049DD6-F9D5-4941-8FC1-83CB425A467AQ46490701-D1B6A6F4-6D2E-4DC1-826D-40DB5C04556A
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dorte Vistisen
@af
Dorte Vistisen
@an
Dorte Vistisen
@ast
Dorte Vistisen
@bar
Dorte Vistisen
@bm
Dorte Vistisen
@br
Dorte Vistisen
@ca
Dorte Vistisen
@co
Dorte Vistisen
@cs
Dorte Vistisen
@cy
type
label
Dorte Vistisen
@af
Dorte Vistisen
@an
Dorte Vistisen
@ast
Dorte Vistisen
@bar
Dorte Vistisen
@bm
Dorte Vistisen
@br
Dorte Vistisen
@ca
Dorte Vistisen
@co
Dorte Vistisen
@cs
Dorte Vistisen
@cy
prefLabel
Dorte Vistisen
@af
Dorte Vistisen
@an
Dorte Vistisen
@ast
Dorte Vistisen
@bar
Dorte Vistisen
@bm
Dorte Vistisen
@br
Dorte Vistisen
@ca
Dorte Vistisen
@co
Dorte Vistisen
@cs
Dorte Vistisen
@cy
P108
P106
P21
P31
P496
0000-0001-5045-5351